| Genotype: a crucial but not unique factor affecting the clinical phenotypes in Fabry disease X Pan, Y Ouyang, Z Wang, H Ren, P Shen, W Wang, Y Xu, L Ni, X Yu, ... PLoS One 11 (8), e0161330, 2016 | 57 | 2016 |
| Kidney failure risk prediction equations in IgA nephropathy: a multicenter risk assessment study in Chinese patients J Xie, J Lv, W Wang, G Li, Z Liu, H Chen, F Xu, J Sun, Y Ouyang, X Zhang, ... American Journal of Kidney Diseases 72 (3), 371-380, 2018 | 54 | 2018 |
| A validation study of crescents in predicting ESRD in patients with IgA nephropathy X Zhang, S Shi, Y Ouyang, M Yang, M Shi, X Pan, J Lv, Z Wang, H Ren, ... Journal of translational medicine 16, 1-8, 2018 | 45 | 2018 |
| Underweight is an independent risk factor for renal function deterioration in patients with IgA nephropathy Y Ouyang, J Xie, M Yang, X Zhang, H Ren, W Wang, N Chen PloS one 11 (9), e0162044, 2016 | 42 | 2016 |
| IgA nephropathy susceptibility loci and disease progression M Shi, Y Ouyang, M Yang, M Yang, X Zhang, W Huang, W Wang, Z Wang, ... Clinical Journal of the American Society of Nephrology 13 (9), 1330-1338, 2018 | 38 | 2018 |
| Clinical significance of plasma globotriaosylsphingosine levels in Chinese patients with Fabry disease Y Ouyang, B Chen, X Pan, Z Wang, H Ren, Y Xu, L Ni, X Yu, L Yang, ... Experimental and therapeutic medicine 15 (4), 3733-3742, 2018 | 32 | 2018 |
| A Rare Genetic Defect of MBL2 Increased the Risk for Progression of IgA Nephropathy Y Ouyang, L Zhu, M Shi, S Yu, Y Jin, Z Wang, J Ma, M Yang, X Zhang, ... Frontiers in immunology 10, 537, 2019 | 25 | 2019 |
| ABO blood type is associated with renal outcomes in patients with IgA nephropathy M Yang, J Xie, Y Ouyang, X Zhang, M Shi, X Li, Z Wang, P Shen, H Ren, ... Oncotarget 8 (43), 73603, 2017 | 20 | 2017 |
| Hypophosphatemia is an independent risk factor for AKI among hospitalized patients with COVID-19 infection Z Chen, C Gao, H Yu, L Lu, J Liu, W Chen, X Xiang, HMJ Hussain, BJ Lee, ... Renal Failure 43 (1), 1329-1337, 2021 | 19 | 2021 |
| Particulate matter of air pollution may increase risk of kidney failure in IgA nephropathy C Luo, Y Ouyang, S Shi, G Li, Z Zhao, H Luo, F Xu, L Shao, Z Chen, S Yu, ... Kidney International 102 (6), 1382-1391, 2022 | 16 | 2022 |
| A validation study comparing risk prediction models of IgA nephropathy Y Ouyang, Z Zhao, G Li, H Luo, F Xu, L Shao, Z Chen, S Yu, Y Jin, J Xu, ... Frontiers in immunology 12, 753901, 2021 | 15 | 2021 |
| Increased lifetime risk of ESRD in familial IgA nephropathy M Shi, S Yu, Y Ouyang, Y Jin, Z Chen, W Wei, Z Fang, W Du, Z Wang, ... Kidney International Reports 6 (1), 91-100, 2021 | 11 | 2021 |
| A validation study of UCSD-Mayo risk score in predicting hospital-acquired acute kidney injury in COVID-19 patients Z Fang, C Gao, Y Cai, L Lu, H Yu, HMJ Hussain, Z Chen, C Li, W Wei, ... Renal Failure 43 (1), 1115-1123, 2021 | 6 | 2021 |
| Globotriaosylsphingosine improves risk stratification of kidney progression in Fabry disease patients Y Ouyang, W Zhang, Z Zhao, C Wang, H Ren, J Xie, X Li, P Shen, H Shi, ... Clinica Chimica Acta 556, 117851, 2024 | 3 | 2024 |
| Oral glucocorticoids with intravenous cyclophosphamide or oral glucocorticoids alone in the treatment of IgA nephropathy present with nephrotic syndrome and … W Du, Z Chen, Z Fang, J Li, Q Weng, Q Zheng, L Xie, H Yu, X Gu, H Shi, ... Clinical Kidney Journal 16 (12), 2567-2577, 2023 | 2 | 2023 |
| Characteristics of clinical manifestations in Chinese Fabry patients Y Ouyang, Y Ouyang, X Pan, Z Wang, X Feng, P Shen, H Ren, L Ni, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 27, 426-426, 2012 | 1 | 2012 |
| Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids X Hu, H Ren, J Xu, C Gao, Y Wu, Y Ouyang, L Lin, X Li, N Liu, W Wang, ... Kidney Diseases 10 (5), 359-368, 2024 | | 2024 |
| Uromodulin and progression of IgA nephropathy Z Chen, L Xu, W Du, Y Ouyang, X Gu, Z Fang, X Yu, J Li, L Xie, Y Jin, J Ma, ... Clinical Kidney Journal 17 (8), sfae209, 2024 | | 2024 |
| # 636 A phase 4, open label, multicenter prospective study of the safety and efficacy of agalsidase beta in Chinese patients with Fabry disease N Chen, H Ren, W Zhang, Y Ouyang, H Xu, B Li, Q Feng Nephrology Dialysis Transplantation 39 (Supplement_1), gfae069-1205-636, 2024 | | 2024 |
| Using Liquid Chromatography-Tandem Mass Spectrometry in Detecting Plasma Lyso-GL3 Levels in Patients with Fabry Disease and the Association Analysis of Phenotype-Genotype of … O Yan, C Bing, PAN Xiaoxia, REN Hong, XIE Jingyuan, W Chaohui, ... Journal of Rare Diseases 3 (1), 42-49, 2024 | | 2024 |
